Press release
Infectious Disease Diagnostics Market: Competitive Intelligence and Tracking Report 2018 – 2026 Danaher Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F.Hoffmann La-Roche Ltd., Cardinal Health, Inc., BioMérieux
Global Infectious Disease Diagnostics Market
Download PDF Brochure Of This Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1971
Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, and conventional culturing, and staining techniques. Biochemical techniques include ELISA, agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.
Advances in molecular testing techniques have resulted in fast diagnosis of infectious diseases in real-time due to which patients can receive treatment early. Commercially available diagnostic tests include BD Max Smart Cycler, GeneXpert, BD Phoenix CPO detect test, Xpert Xpress Strep A, and BioPlex 2200 Syphilis Total & RPR Assay.
Market Dynamics:
Technological advancements to facilitate speedy diagnosis and extensive product portfolios of infectious disease diagnostics offered by manufacturer’s supports the growth of infectious disease diagnostics market. Manufacturers are indulged in providing novel diagnostic solutions for identifying infectious diseases.
For instance, Becton Dickinson and Company launched first automated phenotypic test, BD Phoenix CPO detect test, to detect and classify carbapenemase-producing organisms (CPO) in 2017. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market.
Increasing prevalence of various infectious diseases is expected to boost the infectious disease diagnostics market growth over the forecast period:
Infectious diseases such as HIV, tuberculosis, and malaria are prevalent in emerging economies such as Africa and Asia Pacific. For instance, according to the World Health Organization (WHO), an estimated 36.7 million people were suffering from HIV in 2016.
According to the World Health Organization (WHO), in 2015, an estimated 32,000 deaths from tuberculosis and around 323,000 new cases of TB cases were registered in the Europe. Moreover, around 323,000 incident of TB cases in this region includes 27,000 cases with HIV co-infection.
According to the data published in the Journal of Infection and Public Health, infectious diseases reported the significant causes of deaths in Brazil, in 2016. The high concentration of burden rates observed among men, children under 5 years of age at the coast regions of the state.
According to the Centers for Disease Control and Prevention (CDC), around 5,251 deaths were reported due to influenza infection were registered in 2015. According to the National Ambulatory Medical Care Survey: 2015 data findings, around 16.8 million people visit to physician for treatment of infectious and parasitic diseases in U.S.
According to the World Health Organization (WHO), 2016, around 10.4 million people were affected with tuberculosis and an estimated 1 million pediatric population was affected with tuberculosis. Increasing prevalence of diseases would propel the infectious disease diagnostics market.
Global Key Players:
Some of the major players operating in the global infectious disease diagnostics market include
• Danaher Corporation
• Abbott Laboratories
• Becton
• Dickinson
• Company
• F.Hoffmann La-Roche Ltd.
• Trinity Biotech Plc.
• Cardinal Health, Inc.
• BioMérieux
• Bio-Rad Laboratories, Inc.
• AccuBioTech, Co. Ltd.
• Acon Laboratories, Inc.
Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1971
Detailed Segmentation:
Global Infectious Disease Diagnostics Market, By Product Type:
• Kits & Reagents
• Instruments
Global Infectious Disease Diagnostics Market, By Disease Type:
• HIV
• Hepatitis
• Healthcare Associated Infections (HAIs)
• Human Papillomavirus (HPV)
• Tuberculosis (TB)
• Influenza
• Others
Global Infectious Disease Diagnostics Market, By Technology:
• Immunodiagnostics
• Polymerase Chain Reaction (PCR)
• Next Generation Sequencing (NGS)
• Others
Global Infectious Disease Diagnostics Market, By Test Location:
• Laboratory Testing
• Point-of-Care Testing
Global Infectious Disease Diagnostics Market, By End User:
• Hospitals
• Pathology/Diagnostic Laboratories
• Research Institutes
• Home-Care Settings
• Others
Global Infectious Disease Diagnostics Market, By Geography:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Diagnostics Market: Competitive Intelligence and Tracking Report 2018 – 2026 Danaher Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F.Hoffmann La-Roche Ltd., Cardinal Health, Inc., BioMérieux here
News-ID: 1497709 • Views: …
More Releases from Coherent Market Insights - Clinical Diagnostic
Western Blotting Market is Expected to Gain Popularity Across the Globe by 2026
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives…
Western Blotting Market: Future and Technological Advancement 2026 By Top Player …
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives…
Cannabis Testing Market Expansion to be Persistent During 2018 – 2026 With Top …
Cannabis testing is done for various purpose such as finding concentration of active ingredient (cannabinoids, terpene), which determines the medical potency of the cannabis. It is also tested for determining various other ingredient in given sample. For instance, to determine the pesticide residue content in the given sample that undermines the purity and efficacy. Cannabis testing also involves determination of contaminants such as fungi and bacteria (mycotoxins), which could causes…
Cannabis Testing Market Trends Estimates High Demand By 2026 With Top Key Player …
Cannabis testing products and services market is witnessing significant growth with increased government approval and loosening regulatory stringent ness over use of cannabis for commercial and recreational purpose. For instance, in February 2016, the Australian government amended the Narcotics Drugs Act 1967, to allow cultivation of cannabis for medicinal or scientific purposes under a national licensing scheme, which is expected to favor the growth of the commercial manufacturing of cannabis…
More Releases for Infectious
Increasing Prevalence of Infectious Diseases to Augment the Point-of-Care (POC) …
Point-of-care (POC) diagnosis includes sample testing to facilitate rapid diagnosis and decide on treatment planning accordingly. Infectious diseases often need to be diagnosed early, as they can be fatal against the immune system. POC infectious disease diagnostics allows early detection of diseases and can impact the medical outcome of treatment of the disease.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/63
The U.S. FDA (United States Food and Drug Administration) is…
Infectious Disease Therapeutics Market - Forecasts to 2026
As per the research conducted by GME, the Global Infectious Disease Therapeutics Market is expected to grow from USD 48.77 billion in 2021 to USD 57.21 billion in 2026, at a CAGR of 7.12%. Rising infectious disease, increasing number of surgeries, high prevalence of chronic diseases such as cardiovascular and cancer, rising cases of accidents, changing food habits, lack of proper sanitation measures taken by healthcare providers are some of…
Infectious Disease Diagnostics Market Entry Strategies, Countermeasures, Economi …
Market Expertz has published its latest research study titled 'Global Infectious Disease Diagnostics Market Report Forecast to 2027' gives a detailed assessment of the industry to offer vital information by evaluating the prevalent trends observed in the sector. The report includes valuable market insights provided by the industry experts by way of surveys and interviews as part of primary research. The authors of the study also undertake secondary research, which…
Infectious Disease Diagnostics Market
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $14.82 billion in 2017 and is expected to reach $25.90 billion by 2026 growing at a CAGR of 6.4% during the forecast period. Some of the key factors influencing the market are increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of…
Announcement of Conference: Infectious Disease 2019 | Singapore
With immense pleasure and gratitude, We welcome all the professionals to attend the “International Conference on Pathology and Infectious Diseases” scheduled during November 11-12, 2019 at Singapore.
Infectious Disease 2019 aims to gather the Researchers, Scientists, Professors, Business Delegates experts, Research Scholars and Students working under life science and health care commerce. Infectious Disease conference delivers an international forum for the broadcasting of original research results, new concepts and real-world experiences…
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques.
The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased…
